The 130th Annual Meeting of APHA

Session: HIV Risk among Young Adult Injection Drug Users: Recent Findings from the Second Collaborative Injection Drug Users Study (CIDUS 2) and Similar Studies
4172.0: Tuesday, November 12, 2002: 2:30 PM-4:00 PM
Oral
HIV Risk among Young Adult Injection Drug Users: Recent Findings from the Second Collaborative Injection Drug Users Study (CIDUS 2) and Similar Studies
In the early 90s, researchers recognized the need for early interventions to prevent the spread of bloodborne pathogens such as HIV, hepatitis B and hepatitis C viruses among injection drug users (IDUs). Since then, studies were conducted that attempted to assess the circumstances surrounding initiation of injection drug use, HIV-associated sexual and injection risk behaviors, social network factors, and sociodemographic characteristics of recently initiated IDUs. Given most IDUs do not enter drug treatment programs until they are many years into their addiction, investigators shifted from clinic-based to street-based strategies for recruiting recent-initiate IDUs as study participants. Furthermore, given that median age of initiation is around 19 years, age is a common eligibility criterion for screening out longer-term injectors. In 1997-1999, The Centers for Disease Control and Prevention funded the Second Collaborative Injection Drug Users Study (CIDUS 2) to estimate the prevalence and incidence of HIV, HBV and HCV infections among new injectors and identify behaviors that increase their risk for these infections. This is the Nations largest multisite cohort study of new IDUs that recruited participants who were 18-30 year old or had been injecting for less than 5 years and included Baltimore, Chicago, Los Angeles, New Orleans, and two sites in New York (East Harlem and the Lower East Side). This session will include recent findings from this data set as well as two other studies that recruited from similar populations in Seattle, WA, and Russia. This session is intended to provide the audience with recent findings related to HIV risk among young and recently initiated IDUs
Learning Objectives: In the early 90s, researchers recognized the need for early interventions to prevent the spread of bloodborne pathogens such as HIV, hepatitis B and hepatitis C viruses among injection drug users (IDUs). Since then, studies were conducted that attempted to assess the circumstances surrounding initiation of injection drug use, HIV-associated sexual and injection risk behaviors, social network factors, and sociodemographic characteristics of recently initiated IDUs. Given most IDUs do not enter drug treatment programs until they are many years into their addiction, investigators shifted from clinic-based to street-based strategies for recruiting recent-initiate IDUs as study participants. Furthermore, given that median age of initiation is around 19 years, age is a common eligibility criterion for screening out longer-term injectors. In 1997-1999, The Centers for Disease Control and Prevention funded the Second Collaborative Injection Drug Users Study (CIDUS 2) to estimate the prevalence and incidence of HIV, HBV and HCV infections among new injectors and identify behaviors that increase their risk for these infections. This is the Nations largest multisite cohort study of new IDUs that recruited participants who were 18-30 year old or had been injecting for less than 5 years and included Baltimore, Chicago, Los Angeles, New Orleans, and two sites in New York (East Harlem and the Lower East Side). This session will include recent findings from this data set as well as two other studies that recruited from similar populations in Seattle, WA, and Russia. This session is intended to provide the audience with recent findings related to HIV risk among young and recently initiated IDUs
See individual abstracts for presenting author's disclosure statement and author's information.
Organizer(s):Richard S Garfein, PhD, MPH
Moderator(s):Richard S Garfein, PhD, MPH
2:30 PMHIV risk among young adult injection drug users: Recent findings from the Second Collaborative Injection Drug Users Study (CIDUS 2) and similar studies (SESSION ABSTRACT)
Richard S Garfein, PhD, MPH
2:31 PMCorrelation between housing changes and HIV risk behaviors among young injection drug users (IDUs)
Laura Broyles, MD, Theresa Perlis, PhD, Peter Kerndt, MD, MPH, Edward V Morse, PhD, Lawrence Ouellet, PhD, S.A. Strathdee, PhD, David Vlahov, PhD, Roberto Valverde, MPH, Andrea Swartzendruber, Richard S Garfein, PhD, MPH
2:45 PMFamily system characteristics associated with young IDUs' high risk injecting practices
Edward V Morse, PhD, Patricia M Morse, PhD, Sam Burgess, MA
3:00 PMAssociation of select drug use behaviors and duration of drug use among newly initiated injection drug users
Meredith Becker Buxton, MPH, David Vlahov, PhD, S.A. Strathdee, PhD, Don C. Des Jarlais, PhD, Edward V Morse, PhD, Lawrence Ouellet, PhD, Peter Kerndt, MD, MPH, Richard S Garfein, PhD, MPH
3:15 PMCorrelates of HIV infection among young new initiates to injection drug use in Baltimore, Maryland: 1994-2000
Mahboobeh Safaeian, MPH, Meg Doherty, MD PhD, Crystal Fuller, MPH, PhD, Susan G. Sherman, MPH, PhD, Danielle C. Ompad, MHS, David Vlahov, PhD, S.A. Strathdee, PhD
3:30 PMYoung age vs. years injecting: A birth cohort analysis of HIV risk in Seattle IDUs
Holly Hagan, PhD, Hanne Thiede, DVM, MPH
3:45 PMDrug use and HIV risk behavior among syringe exchange participants in Eastern Europe and the U.S
Don Des Jarlais, PhD
Organized by:Alcohol, Tobacco, and Other Drugs
Endorsed by:Epidemiology; HIV/AIDS; School Health Education and Services; Socialist Caucus
CE Credits:CME, Health Education (CHES), Nursing, Pharmacy, Social Work

The 130th Annual Meeting of APHA